Newgenivf Group LTD Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
NewGenIvf Group Ltd director Siu Wing Fung Alfred acquired employee share options under the company's 2024 Share Incentive Plan.
NASDAQ
NewGenIvf Group Ltd reports the grant of employee share options to Director Hei Yue Tina Fong under the 2024 Share Incentive Plan.
NASDAQ
HRT FINANCIAL LP has disclosed a new beneficial ownership stake in NewGenIvf Group Ltd (NIVF), acquiring 18,134 shares of common stock.
NASDAQ
Director Siu Wing Fung Alfred acquired 56,851 Class B Ordinary Shares of NewGenIvf Group Ltd through the exercise of vested stock options.
NASDAQ
Director Hei Yue Tina Fong acquired 56,851 Class B Ordinary Shares of NewGenIvf Group Ltd through the exercise of vested stock options.
NASDAQ
HRT Financial LP reported the acquisition of NewGenIvf Group Ltd common stock on June 2nd and 3rd, 2026.
NASDAQ
HRT Financial LP reported the sale of 85,317 shares of NewGenIvf Group Ltd common stock at a price of $0.80 per share.
NASDAQ
HRT Financial LP reported the acquisition of common stock in NewGenIvf Group Ltd on May 22 and May 26, 2026.
NASDAQ
NewGenIvf Group Ltd's Chairman & CEO, Siu Wing Fung Alfred, has been granted stock options to acquire 56,851 Class B Ordinary Shares.
NASDAQ
NewGenIvf Group Ltd reports the grant of stock options to Chief Marketing Officer Tina Fong Hei Yue, with vesting over several years and an expiration in 2033.
NASDAQ
A SPAC I Acquisition Corp. announces the adjournment of its special meeting of shareholders to March 4, 2024, concerning the proposed transaction with NewGenIvf.